CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-13

lol. And to put my money where my mouth is i added another total 350k shares this week. 194k yesterday at an average of 25.78. I’m going to be sitting watching the screen today with a bucket of popcorn

AMAZING the difference in valuation:

sight sciences USD market cap 371 vs revenue 80m = 4.64 times revenue when they are:
- predicting ZERO growth and
- burning cash at around $15-$20m a qtr and no obvious path to CF+

EYE if you transfer market cap to USD so like for like would be $37m vs $15.3m revenue = 2.5 time revenue on
- 77% growth in US sales and
- clear path to CF+ in 9-12 months plus arguably funded to get there.

SURELY EYE should be valued on the same multiple which would give a MINIMUM valuation of 47c. But logic would say given the growth profile their multiple should be more like 8-10X revenue or a shareprice of 80c-$1

hopefully today brings enough attention to rip the bandaid off, smash 30c in the face on the way through and get the real rerate hottub party started